4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-042291
SVP and General Counsel sold 4,166 shares at $40.00 ($166,640)
- SVP and General Counsel acquired 4,166 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taylor Stacy L SVP and General Counsel | 2021-06-17 | Option exercise | +1,041 | $7.80 | $8,120 | 16,077 | D: show line 1 in the form |
| Taylor Stacy L SVP and General Counsel | 2021-06-17 | Option exercise | +1,771 | $6.55 | $11,600 | 17,848 | D: show line 2 in the form |
| Taylor Stacy L SVP and General Counsel | 2021-06-17 | Option exercise | +1,354 | $31.71 | $42,935 | 19,202 | D: show line 3 in the form |
| Taylor Stacy L SVP and General Counsel | 2021-06-17 | Sale | −4,166 | $40.00 | $166,640 | 15,036 | D: show line 4 in the form |
| Open-market sales · 4,166 sh · avg $40.00 · $166,640 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Taylor Stacy L SVP and General Counsel | 2021-06-17 | Option exercise · Stock Option (Right to Buy) | −1,041 | 23,959 | D: show line 5 in the form | |||||
| Taylor Stacy L SVP and General Counsel | 2021-06-17 | Option exercise · Stock Option (Right to Buy) | −1,771 | 17,709 | D: show line 6 in the form | |||||
| Taylor Stacy L SVP and General Counsel | 2021-06-17 | Option exercise · Stock Option (Right to Buy) | −1,354 | 44,688 | D: show line 7 in the form |
Loading xslF345X03/doc4.xml…